MK-0431A XR in Pediatric Patients with Type 2 Diabetes Mellitus and Inadequate Glycemic Control on Metformain

Update Il y a 4 ans
Reference: EUCTR2012-004035-23

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

In pediatric subjects with inadequate control on metformin therapy, after 20 weeks: 1. To asses)s the effect of the addition of sitagliptin (MK-0431A XR) compared with the addition of placebo on A1C 2. To assess the safety and tolerability of the addition of sitagliptin (MK-0431A XR


Inclusion criteria

  • Type 2 diabetes mellitus